Found 6 matching trials
A Phase I/II Trial of a Tetravalent Live Attenuated DEN Vaccine in Flavivirus Antibody Naive Children
PHASE1One year follow-up on immunogenicity and safety of a booster dose of DEN va...
Location
Department of Pediatrics, Phramongkutklao Hospital
A Phase II Trial of a Live Attenuated Virus Tetravalent Dengue Vaccine in Healthy Adults in Thailand
PHASE2This descriptive study will evaluate the safety and immunogenicity of diffe...
Location
Phramongkutklao Hospital
A Study of Two Doses of WRAIR Dengue Vaccine Administered Six Months Apart to Healthy Adults and Children
PHASE2The purpose of this study is to evaluate the safety and effectiveness of tw...
Location
San Juan Batista Medical School
A Phase I/II Trial of Tetravalent Live Attenuated Dengue Vaccine in Flavivirus Antibody Naive Infants
PHASE1The main target populations for the tetravalent live attenuated dengue viru...
Location
USAMC-AFRIMS/Department of Pediatrics, Pharamongkutklao Hospital
A Phase I/II Trial of a Tetravalent Live Attenuated Dengue Vaccine in Flavivirus Antibody Naïve Children
PHASE1To assess the safety, reactogenicity and immunogenicity of two doses of the...
Location
Department of Pediatrics, Pharamongkutklao Hospital
Safety and Immunogenicity of Various Formulations of Live Attenuated Tetravalent Dengue Vaccine in Healthy US Adults
PHASE2This descriptive study will evaluate the safety and immunogenicity of 3 dif...
Location
Walter Reed Army Institute of Research